Barun Chanda

Chanda's screen career effectively begins with one of Indian cinema's landmark films. Satyajit Ray cast him as Shyamalendu Chatterjee in *Seemabaddha* (1971) — a corporate climber whose moral compromises Ray examines with characteristic precision. It's a demanding lead role, and Chanda held it. That film alone would be enough for most actors to retire on. He didn't retire. Through the 1990s and 2000s, he built steadily in Bengali cinema: Rituparno Ghosh's *Hirer Angti* in 1992, then Anurag Kar's *Antaheen* in 2009, a film that paired him with a generation of Bengali stars in a story about urban longing and disconnection. *Hemlock Society* (2012, directed by Sudesh Roy) followed, and then — somewhat unexpectedly — a Bollywood credit in Vikram Bhatt's *Lootera* (2013). Hard to say if mainstream Hindi cinema ever quite knew what to do with him, but the credit stands. Srijit Mukherji's ensemble thriller *Chotushkone* (2014) brought him back to Bengali territory, where he's always seemed most at home. The stretch from 2019 onward has been genuinely impressive for an actor in his late seventies. *Rakkhosh* (2019) cast him as psychiatrist Dr. Idris Shah in what was billed as India's first POV cinema-shot thriller — a technical experiment that required its cast to perform for a camera perspective that mimics a single human eye. In 2022, he portrayed Jawaharlal Nehru in Anik Dutta's *Aparajito* (TMDB). That same year brought *Toolsidas Junior*. Then 2023: *Chor Nikal Ke Bhaga*, where he played Home Minister Harish Sanyal, and *Mrs. Chatterjee vs Norway*. Upcoming projects including *Dispersion*, plus 2025 releases *Nadaaniyan* and *Re-Routing*, suggest he's not treating any of this as a wind-down (TMDB). Beyond acting, Chanda has published fiction and non-fiction — *Murder in the Monastery* (a crime thriller set in Sikkim), *Coke*, *Robibar*, and *Satyajit Ray: The Man Who Knew Too Much*, the last of which puts him in the unusual position of having been directed by Ray and then written about him (Wikipedia). Not many people can claim both.